Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7


Chimeric hepatitis E virus-like particle as a carrier for oral-delivery.

Jariyapong P, Xing L, van Houten NE, Li TC, Weerachatyanukul W, Hsieh B, Moscoso CG, Chen CC, Niikura M, Cheng RH.

Vaccine. 2013 Jan 2;31(2):417-24. doi: 10.1016/j.vaccine.2012.10.073. Epub 2012 Oct 26.


Developing strategies to enhance and focus humoral immune responses using filamentous phage as a model antigen.

Henry KA, Murira A, van Houten NE, Scott JK.

Bioeng Bugs. 2011 Sep-Oct;2(5):275-83. doi: 10.4161/bbug.2.5.16559. Epub 2011 Sep 1.


Engineering filamentous phage carriers to improve focusing of antibody responses against peptides.

van Houten NE, Henry KA, Smith GP, Scott JK.

Vaccine. 2010 Mar 2;28(10):2174-2185. doi: 10.1016/j.vaccine.2009.12.059. Epub 2010 Jan 5.


Exploring peptide mimics for the production of antibodies against discontinuous protein epitopes.

Irving MB, Craig L, Menendez A, Gangadhar BP, Montero M, van Houten NE, Scott JK.

Mol Immunol. 2010 Feb;47(5):1137-48. doi: 10.1016/j.molimm.2009.10.015. Epub 2009 Dec 23.


The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: dominant site of antibody neutralization and target for vaccine design.

Montero M, van Houten NE, Wang X, Scott JK.

Microbiol Mol Biol Rev. 2008 Mar;72(1):54-84, table of contents. doi: 10.1128/MMBR.00020-07. Review.


Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodies.

Saphire EO, Montero M, Menendez A, van Houten NE, Irving MB, Pantophlet R, Zwick MB, Parren PW, Burton DR, Scott JK, Wilson IA.

J Mol Biol. 2007 Jun 8;369(3):696-709. Epub 2007 Jan 27.


Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.

van Houten NE, Zwick MB, Menendez A, Scott JK.

Vaccine. 2006 May 8;24(19):4188-200. Epub 2006 Jan 11.

Supplemental Content

Loading ...
Support Center